Article Details
Retrieved on: 2021-04-03 10:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
and Catalent, Inc. announced a collaboration for large-scale, commercial fill-finish manufacturing of Moderna's mRNA-based COVID-19 vaccine ...
Article found on: jumbonews.co.uk
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here